Table 3.
GC-mediated molecular mechanisms involved in reducing GRα expression.
Level of regulation | Molecular mechanism | Species | GRα mRNA expression | GRα protein expression | References |
---|---|---|---|---|---|
Epigenetic | DNA methylation of GRα gene • Rodents: exon 17 • Humans: exon 1F, exon 1C, exon 1B, exon 1H, exon 1D |
Rodent Human |
Reduced Reduced |
Reduced Reduced |
(30, 32, 33, 42)(24, 25, 81, 92) |
Transcriptional | GRα gene regulation via nGREa • Present in exon 6 |
Human | Reduced | N.Db | (107) |
Post-transcriptional | miRNA • Rodents: miR-96, miR-101a, miR-142-3p, miR-433, miR-29b, miR-340-5p, miR-18 and miR-124a • Humans: miR-124, miR-130b and miR-142-3p |
Rodent Human |
Reduced Reduced |
Reduced Reduced |
(38, 40, 42, 127, 128, 129)(84, 89, 95, 130) |
Post-translational | Phosphorylation • Rodents: ◦ Multiple mouse mutations(Ser212, Ser220 and Ser234) ◦ Hyper-phosphorylation at Ser412 • Humans: hyper-phosphorylation at Ser211, Ser226 and Ser404 |
Mouse Human |
N.Ac N.A |
Decreased Decreased |
(136, 137)(135, 136) |
Ubiquitination • Rodents: K426 • Humans: K419 Proteasome degradation (i.e. use of proteasome inhibitors) • Rodents: MG132 or bortezomib (BZ) • Humans: MG132 or BZ |
Mouse Human Mouse Human |
N.A N.A N.A N.A |
Decreased Decreased Decreased Decreased |
(99, 104, 105, 139, 142)(105, 141, 143, 144, 145, 146)(99, 104, 105, 139, 142)(105, 141, 143, 144, 145, 146) | |
Sumoylation • Specific site unknown |
Human | N.A | Decreased | (152) |
aNegative glucocorticoid response element (nGRE), bNot detected (N.D), cNot applicable (N.A) as effects exerted on GRα protein.